RS
SEC Insider//CIK 0001664852
Requadt Scott
CIK 00016648526 companiesVANCOUVER, A1
Transactions
43
Companies
6
Filings
15
CIK
0001664852
Recent Transactions
- Disposition to Issuer
- Award
- Other
- Other
- Tax Payment
- Award
- Award
- Award
- Award
- Purchase
- Purchase
- Purchase
- Purchase
- Award
- Award
- Award
- Award
- Award
- Award
- Conversion
Series B-1 Tranche A Convertible Preferred Stock
2018-09-28−6,702,213→ 0 total - Conversion
- Conversion
Series B-1 Tranche B Convertible Preferred Stock
2018-09-28−8,552,024→ 0 total - Conversion
- Purchase
- Conversion
- Conversion
- Conversion
- Purchase
- Conversion
- Conversion
- Conversion
- Conversion
- Conversion
- Conversion
- Conversion
- Conversion
- Conversion
- Exercise/Conversion
- Exercise/Conversion
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
Companies
6Recent Filings
15- 4
Requadt Scott
Oct 15, 2025
- 4
Requadt Scott
Mar 28, 2024
- 4
Requadt Scott
Jan 16, 2024
- 4
Requadt Scott
Jul 6, 2023
- 4
Requadt Scott
Feb 3, 2023
- 4
Requadt Scott
Nov 1, 2022
- 4
Requadt Scott
Sep 13, 2022
- 4
Requadt Scott
Aug 2, 2022
- 4
Requadt Scott
Jul 28, 2022
- 4
Requadt Scott
Jul 26, 2022
- 4
Requadt Scott
Feb 2, 2022
- 4/A
Requadt Scott
Jan 26, 2021
- 4
Requadt Scott
Jan 11, 2021
- 4
Requadt Scott
Feb 4, 2019
- 4
Clarus Lifesciences III, L.P.
Oct 2, 2018
Address
C/O ESSA PHARMA INC. 999 WEST BROADWAY, SUITE 720
VANCOUVER, A1, V5Z 1K5